Enalapril and hydrochlorothiazide in hypertensive Africans
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 36 (3) , 229-234
- https://doi.org/10.1007/bf00558152
Abstract
The antihypertensive efficacy both of angiotensin converting enzyme (ACE) inhibitors and thiazide diuretics has been claimed to be influenced by plasma renin activity, which declines with age and is low in blacks. In a double-blind, placebo-controlled, double-dummy, randomized, parallel-group preliminary study, the antihypertensive efficacy and tolerability of the ACE inhibitor enalapril (20 mg day−1) and hydrochlorothiazide (50 mg day−1) were evaluated and compared for 4 weeks in 20 African patients with essential hypertension. The two groups had similar baseline clinical features and serum Na+ and K+ levels. Hydrochlorothiazide caused a significant and sustained fall in erect blood pressure with a reflex tachycardia. Enalapril exerted only a modest antihypertensive action, but significantly reduced erect heart rate. Direct comparison of hydrochlorothiazide — and enalapril — induced hypotension suggested a greater fall in subjects on the thiazide. The 95% confidence limits for the thiazide-enalapril difference in antihypertensive action at the end of the study was 39.5 to −7.5 mm Hg systolic and 22.0 to −6.6 mm Hg diastolic. The maximal blood pressure fall after hydrochlorothiazide was positively correlated with age (r=0.50;pr=−0.57,p<0.05). The results are compatible with the notion that ACE inhibitor monotherapy may be less effective than thiazide diuretic treatment in African and black patients with essential hypertension. The findings also support the concept that age and racial factors may influence the response to antihypertensive treatment.This publication has 27 references indexed in Scilit:
- Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions‐parallels and contrasts.British Journal of Clinical Pharmacology, 1987
- Monotherapy with Nifedipine for Essential Hypertension in Adult BlacksJournal of Cardiovascular Pharmacology, 1986
- Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.British Journal of Clinical Pharmacology, 1986
- Cough and Wheeze Caused by Inhibitors of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1986
- Acute and Chronic Effects of the Converting Enzyme Inhibitors Enalapril and Lisinopril on Reflex Control of Heart Rate in Normotensive ManJournal Of Hypertension, 1985
- An overview of the clinical pharmacology of enalapril.British Journal of Clinical Pharmacology, 1984
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeNew England Journal of Medicine, 1977
- Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertensionThe American Journal of Cardiology, 1975
- Volume factor in low and normal renin essential hypertension: Treatment with either spironolactone or chlorthalidoneThe American Journal of Cardiology, 1973
- Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profilesThe American Journal of Medicine, 1973